Pancreatic Cancer Research

ResearcherVan Andel InstituteNo recent work listed

Luke Wisniewski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1905-4992; OpenAlex author ID A5006453909. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: 1 paper

Papers 3

  1. Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1135405↗
  2. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues. Co-author DOI 10.1074/mcp.ra120.002256↗
  3. Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. First author DOI 10.1158/1078-0432.ccr-20-2475↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brian B. Haab · 3 shared papers, 2021–2023 · strength 0.43
  2. Peter J. Allen · 2 shared papers, 2021–2023 · strength 0.31
  3. ChongFeng Gao · 2 shared papers, 2021–2023 · strength 0.31
  4. Richard R. Drake · 2 shared papers, 2021 · strength 0.22
  5. Chanjuan Shi · 1 shared paper, 2023 · strength 0.20
  6. Colin T. McDowell · 1 shared paper, 2021 · strength 0.12
  7. Ying Liu · 1 shared paper, 2021 · strength 0.10
  8. Amer H. Zureikat · 1 shared paper, 2021 · strength 0.10
  9. Daniel Barnett · 1 shared paper, 2021 · strength 0.10
  10. Ben Staal · 1 shared paper, 2021 · strength 0.10
  11. Mohammed Aldakkak · 1 shared paper, 2021 · strength 0.10
  12. Douglas B. Evans · 1 shared paper, 2021 · strength 0.10
  13. Randall E. Brand · 1 shared paper, 2021 · strength 0.10
  14. Susan Tsai · 1 shared paper, 2021 · strength 0.10
  15. David Arthur Tuveson · 1 shared paper, 2021 · strength 0.10
  16. Aatur Dilip Singhi · 1 shared paper, 2021 · strength 0.10
  17. Ying Huang · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.